LoginSignup
Imagen de perfil
Seventrader
@7Trader
2Lun·

On Friday I quickly bought another 40 shares of $SHL (-1,01 %) Siemens Healthineers (including Varian). AI has long since made inroads here too and medical technology will make progress year after year. I also expect the next acquisitions of smaller companies in the coming years and so, in addition to organic growth, some will also be purchased.

In the long term, the stock can only win.

attachment
17.10
Siemens Healthineers logo
Compró 40 a 52,58 €
2103,20 €
Imagen de perfil
Seventrader
@7Trader
5Lun·

I have spontaneously increased my position in Siemens Healthineers $SHL (-1,01 %) spontaneously by 50%.

I like the continuous growth in profits and dividends and the ongoing acquisitions.


The two robotic systems Artis-System and Corindus-System are direct competitors to Intuitiv Surgical in some areas.

Both can be read here:

Siemens Healthineers Artis System:
https://www.siemens-healthineers.com/clinical-specialities/surgery/surgery-product-portfolio/hybrid-or/artis-pheno

Siemens Healthineers Corindus System:
https://www.massdevice.com/siemens-healthineers-cuts-corindus-surgical-robotics/


The merger (USD 16 billion) of Varian Medical Systems in 2019 marked an important step in the field of cancer and radiotherapy.


I could be wrong, but I am very much convinced that this company will become stronger and stronger in the future and that the share price will rise steadily.

🤑🤞🏼

11.07
Siemens Healthineers logo
Compró 50 a 54,82 €
2741,00 €
previw image
www.siemens-healthineers.comARTIS pheno
16
1 Comentario
Ziyang@Yang
1Lun
How do you comment on the weak sales in China? Siemens will be publishing its figures soon and the Chinese business will probably suffer a lot, as will most companies.
••
Únase a la conversación
InscríbaseInicio de sesión